Bavdekar A R, Bhave S A, Pradhan A M, Pandit A N, Tanner M S
Department of Paediatrics, King Edward Memorial Hospital, Pune, India.
Arch Dis Child. 1996 Jan;74(1):32-5. doi: 10.1136/adc.74.1.32.
Indian childhood cirrhosis (ICC) is an almost uniformly fatal disease whose outcome may be modified with penicillamine if given at a sufficiently early stage. Twenty nine children with ICC seen in Pune, India, in 1980-7, who had survived at least five years from onset of penicillamine treatment, were reviewed aged 6.3 to 13 years. They were assessed clinically, biochemically, histologically, and by duplex Doppler ultrasound examination. None had symptoms suggestive of liver disease. There were no toxic effects of penicillamine other than asymptomatic proteinuria. Hepatosplenomegaly reduced significantly and liver function tests returned to normal in all. In four children, significant hepatosplenomegaly was associated with an abnormal duplex Doppler hepatic vein flow pattern and micronodular cirrhosis on biopsy. Clinical findings, growth and development, and ultrasound examination were normal in the remainder. Review of serial liver biopsy specimens showed a sequence of recovery from ICC through inactive micronodular cirrhosis to virtually normal histological appearances. The four children who still have micronodular cirrhosis beyond four years from onset remain on penicillamine treatment. In the others penicillamine was stopped after 1-7 (mean 3.5) years without relapse, strong evidence that ICC is not due to an inborn error of copper metabolism.
印度儿童肝硬化(ICC)是一种几乎必然致命的疾病,如果在足够早的阶段给予青霉胺,其预后可能会得到改善。对1980年至1987年间在印度浦那就诊的29例ICC患儿进行了回顾性研究,这些患儿自开始使用青霉胺治疗后至少存活了5年,年龄在6.3岁至13岁之间。对他们进行了临床、生化、组织学评估以及双功多普勒超声检查。无一例有提示肝脏疾病的症状。除无症状蛋白尿外,青霉胺没有其他毒性作用。所有患儿的肝脾肿大均显著减轻,肝功能检查恢复正常。4例患儿肝脾显著肿大,活检显示双功多普勒肝静脉血流模式异常及小结节性肝硬化。其余患儿的临床检查、生长发育及超声检查均正常。对系列肝活检标本的回顾显示,ICC从恢复到静止性小结节性肝硬化,直至组织学表现几乎正常的过程。4例自发病后4年仍有小结节性肝硬化的患儿继续接受青霉胺治疗。其他患儿在1至7年(平均3.5年)后停用青霉胺且未复发,有力证明ICC并非由先天性铜代谢缺陷所致。